| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |